Premium Content Regulatory alerts
SMC accepts epidyolex® with clobazam for Dravet syndrome and Lennox-Gastaut syndrome
Several phase III trials showed Epidyolex® reduced seizure frequency in adults and children whose condition is inadequately controlled by other anti-epileptic drugs.
Please sign in or register for FREE
Sign in to OnMedica
Or sign in via